Direct thrombin inhibitors are theoretically likely to be more effective than indirect thrombin inhibitors, such as unfractionated heparin (UFH) or low molecular weight heparin (LMWH), because the ...
Antithrombotic drug strategies used in the PCI setting include traditional indirect thrombin inhibitors (unfractionated heparin [UFH], low-molecular-weight heparins [LMWHs]) and, most recently ...
In March 2008, the European Commission granted marketing authorization for dabigatran etexilate (Pradaxa; Boehringer Ingelheim), a direct thrombin inhibitor, for the prevention of venous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback